EUCTR2005-001084-56-IT进行中（未招募）不适用
Phase II Multiple-Dose Clinical Trial of Oral ITF 2357 In Patients with Advanced Multiple Myeloma
ITALFARMACO0 个研究点目标入组 34 人开始时间: 2005年6月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Phase II High Pulse Dose Clinical Trial of Orally Administered ITF 2357 In Patients with Relapsed/Refractory Multiple Myeloma - NDPatients with Relapsed/Refractory Multiple MyelomaMedDRA version: 9.1Level: HLTClassification code 10028229Term: Multiple myelomasEUCTR2008-001416-20-ITITALFARMACO22
未知
1 期
Phase I, Multiple Oral Dose Study to Evaluate the Tolerability and Pharmacokinetics of Favipiravir in Healthy VolunteersJPRN-jRCT2080222606Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)10
尚未招募
不适用
A Clinical Trial to Analyze the effect of oral intake of Phellinus linteus(sanghuang) Extract on immune function: Randomized, Double-blind Controlled TrialKCT0005460Cheonan Korean Medicine Hospital of Daejeon University98
已完成
不适用
Safety evaluation of long-term NMN in healthy peopleJPRN-jRCTs031180242Itoh Hiroshi30
进行中（未招募）
1 期
A Phase 2 clinical trial of orally taken investigational product (called MLN9708) in adult patients with returning and/or not responding Follicular LymphomaMedDRA version: 14.1Level: LLTClassification code 10029478Term: Nodular lymphomaSystem Organ Class: 100000004864Follicular LymphomaEUCTR2013-002302-32-ITMillennium Pharmaceuticals, Inc.58